Verified

Expired

Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate Cancer

Pfizer

This competitive grant program seeks to fund high-impact Independent Medical Education (IME) initiatives designed to address critical knowledge, skill, and confidence gaps among healthcare professionals (HCPs) regarding Homologous Recombination Repair mutation (HRRm) testing in metastatic prostate cancer (mPC).

The goal of this RFP is to move beyond foundational knowledge and equip the multidisciplinary team with the practical skills needed to support guideline-based HRRm testing across the patient care pathway. This includes a deep focus on the pre-analytical phase, where specimenrelated factors may affect testing feasibility and quality, as well as advanced skills in interpreting, communicating and applying HRRm testing information in clinical practice. Projects should prioritize educational interventions that equip HCPs with knowledge, competencies, and confidence needed to evaluate and apply guideline-recommended HRRm testing approaches in clinical practice. Proposals should demonstrate measurable impact on learner knowledge, competence, and confidence in testing-related decision-making, multidisciplinary collaboration, and application of guideline-based testing pathways.

Project Types and Area of Interest

A key priority of this RFP is bridging the academic-community practice gap. Programs that provide practical educational resources, case-based learning, best-practice considerations in HRRm testing from specimen acquisition through biomarker-informed treatment decisionmaking, or educational frameworks that support HCPs in applying evidence-based testing recommendations in routine clinical practice are particularly encouraged. Proposals should be comprehensive and address topics across the following key educational domains:

• Domain 1: Pre-Analytical and Multidisciplinary Considerations Across the HRRm Testing Pathway

• Domain 2: Clinical Rationale and Guideline-Based Considerations for HRRm Testing

• Domain 3: Applying and Communicating HRRm Testing Results in Clinical Practice

Funding Range and Project Length

Total available budget related to this RFP is approximately $300,000.00. Individual projects covering multiple countries requesting up to $100,000 will be considered. Smaller projects are also encouraged (e.g. $30,000-$50,000). Maximum project length is 12 months.

AI Based Application Success Predictor

Direct alignment with Pfizer’s therapeutic focus areas, such as:
- Oncology
- Vaccines
- Inflammation & Immunology
- Rare diseases
Projects addressing unmet medical needs are prioritized

👉 Misalignment with Pfizer’s current RFP (Request for Proposals) is a major rejection factor

🎯 2. Clear Impact on Patient Outcomes

Pfizer strongly favors proposals that demonstrate:

Improved patient care or clinical outcomes
Real-world applicability (not purely theoretical research)
Measurable endpoints (e.g., survival, quality of life, adherence)

👉 Compared to academic grants, practical impact is more heavily weighted

🧪 3. Robust Study Design & Methodology

Successful applications typically include:

Well-defined study protocols
Appropriate statistical plans
Feasible recruitment strategies

👉 Weak methodology is one of the most common rejection reasons

👩‍⚕️ 4. Investigator Credentials & Track Record

Proven publication record in the relevant field
Prior clinical research experience
Institutional support and infrastructure

👉 Early-career applicants can succeed, but usually with:

Strong mentorship
Clear feasibility

🏥 5. Institutional Capability

Access to:
- Patient population
- Clinical facilities
- Data management systems
Experience in conducting industry-sponsored trials

🤝 6. Independence & Transparency

For Pfizer grants (especially IIR):

Research must be investigator-initiated and independent
Clear disclosure of:
- Conflicts of interest
- Data ownership
Pfizer does not control study outcomes

💰 7. Realistic & Justified Budget

Budget must align with:
- Study scope
- Timeline
Overinflated or vague budgets reduce success chances

📑 8. Compliance with RFP Requirements

Strict adherence to:
- Proposal format
- Submission guidelines
- Required documentation

👉 Non-compliance can lead to automatic disqualification

🌍 9. Geographic & Strategic Priorities

Pfizer often prioritizes:
- Regions with high disease burden
- Projects aligned with global health strategies

⏳ 10. Feasibility & Timeline

Clearly achievable milestones
Realistic timelines
Defined deliverables

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Alignment with Pfizer RFP & therapeutic area
Patient-centered impact
Strong methodology

Moderate predictors:
4. Investigator track record
5. Institutional capability
6. Feasibility

Supporting factors:
7. Budget clarity
8. Compliance
9. Independence & transparency

💡 Insider Insight

Unlike Horizon Europe or NIH-type grants:

👉 Pfizer funding is more application-driven than theory-driven
👉 “Will this improve patient care soon?” is the central evaluation lens

Specialties

Cancer

Oncology

Eligibility Requirements

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).

• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.

• The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).

• The project/program lead must be an employee or contractor of the requesting organization.

• Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.

• For projects offering continuing education credit, the requesting organization must be accredited.

• For Italy only, Educazione Continua in Medicina (ECM) events will not be supported. Only non-ECM initiatives will be evaluated.

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Sponsor Type: Corporate/Non-Profit

Address: 66 Hudson Boulevard East, New York, NY 10001

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity